Transfusion-Induced Alterations of Pulmonary and Immune Function in Mechanically Ventilated Patients
NCT00751322 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2012-01-31
Summary
Specific aim: To test whether transfusion of leukoreduced red cells of lesser storage time (versus conventional storage time) reduces mild alterations in pulmonary function and immune activation in critically ill patients with mechanically ventilated lungs.
We propose to perform a prospective, randomized, double-blind clinical trial in critically ill patients whose lungs are mechanically ventilated, and who have orders to receive transfusion of at least one unit of packed red cells, comparing pulmonary function between patients randomly allocated to receive a unit of red cells stored for 5 days or less, with similar patients randomly allocated to receive a unit of red cells stored conventionally (median 21 days). We will test the hypothesis that transfusion of red cells of lesser storage age, (5 days or less) will produce the less changes of pulmonary function and immune activation than will transfusion of red cells of conventional storage age (median 21 days).
Conditions
- Pulmonary Edemas
- Blood Protein Disorders
Interventions
- OTHER
-
RBC transfusion of 5 days or less storage age
RBC transfusion of 5 days or less storage age
- OTHER
-
RBC transfusion of conventional storage age
RBC transfusion of conventional storage age
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Ognjen Gajic, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2010-07-31
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
NCT02549222 ·Status: COMPLETED
-
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
NCT00223483 ·Status: COMPLETED
-
Home Blood Transfusions
NCT07121140 ·Status: RECRUITING ·Phase: NA
-
Immunomodulation Effect of Blood Transfusion
NCT02140216 ·Status: COMPLETED
-
POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units
NCT03056378 ·Status: WITHDRAWN ·Phase: PHASE1
-
Clinical Efficacy of Platelet Transfusion
NCT06805097 ·Status: RECRUITING
-
Pathological Myeloid Activation After Sepsis and Trauma
NCT05616130 ·Status: RECRUITING
-
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT03557749 ·Status: TERMINATED
-
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673 ·Status: COMPLETED ·Phase: PHASE2
-
Rejuvenated RBC and VO2 Max in Healthy Subjects
NCT03089047 ·Status: TERMINATED ·Phase: PHASE4
-
Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT.
NCT06837987 ·Status: COMPLETED
-
Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
NCT00758992 ·Status: COMPLETED
-
Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)
NCT01278927 ·Status: COMPLETED ·Phase: NA
-
Markers of Inflammation in Hematopoietic Stem Cell Transplant
NCT00579397 ·Status: COMPLETED
-
Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
NCT01879072 ·Status: COMPLETED
-
Mild Pulmonary Function Changes With Transfusion
NCT00681954 ·Status: COMPLETED
-
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
NCT00770523 ·Status: COMPLETED
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies
NCT02885038 ·Status: COMPLETED
-
Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery
NCT05607940 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Longitudinal Gene Expression Profiling in Adults After Traumatic Injury
NCT02656459 ·Status: COMPLETED
-
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
NCT06729320 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Granulocyte Transfusion Study
NCT00000581 ·Status: COMPLETED ·Phase: PHASE3
-
Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
NCT00202371 ·Status: WITHDRAWN ·Phase: PHASE4
-
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
NCT02579967 ·Status: RECRUITING ·Phase: PHASE2